risperidone has been researched along with Brain Neoplasms in 9 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide (TMZ) has been the first-line chemotherapeutic agent used, although to achieve a satisfactory clinical effect." | 5.51 | Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. ( Gao, L; Huang, X; Jiang, X; Li, J; Liu, X; Liu, Z; Zeng, T, 2019) |
| "Temozolomide (TMZ) has been the first-line chemotherapeutic agent used, although to achieve a satisfactory clinical effect." | 1.51 | Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. ( Gao, L; Huang, X; Jiang, X; Li, J; Liu, X; Liu, Z; Zeng, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Wang, T | 1 |
| Wan, Q | 1 |
| Wang, Q | 1 |
| Chen, Z | 1 |
| Gao, Y | 1 |
| Ye, Y | 1 |
| Lin, J | 1 |
| Zhao, B | 1 |
| Wang, H | 1 |
| Yang, J | 1 |
| Zhao, K | 1 |
| Lu, N | 1 |
| Stupinski, J | 1 |
| Kim, J | 1 |
| Francois, D | 1 |
| Liu, Z | 1 |
| Jiang, X | 1 |
| Gao, L | 1 |
| Liu, X | 1 |
| Li, J | 1 |
| Huang, X | 1 |
| Zeng, T | 1 |
| Lapeire, LD | 1 |
| Tansens, A | 1 |
| Lemmens, GM | 1 |
| Van Belle, SJ | 1 |
| Zugman, A | 1 |
| Pan, PM | 1 |
| Gadelha, A | 1 |
| Mansur, RB | 1 |
| Asevedo, E | 1 |
| Cunha, GR | 1 |
| Silva, PF | 1 |
| Brietzke, E | 1 |
| Bressan, RA | 1 |
| Karakurum, B | 1 |
| Karatas, M | 1 |
| Yildirim, T | 1 |
| Nakaji, P | 1 |
| Meltzer, HS | 1 |
| Singel, SA | 1 |
| Alksne, JF | 1 |
| De León, OA | 1 |
| Jobe, TH | 1 |
| Furmaga, KM | 1 |
| Gaviria, M | 1 |
| Lee, MA | 1 |
| Leng, ME | 1 |
| Tiernan, EJ | 1 |
9 other studies available for risperidone and Brain Neoplasms
| Article | Year |
|---|---|
TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
Topics: Brain Neoplasms; Caveolin 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Humans; Neop | 2022 |
Delusional Disorder Arising From a CNS Neoplasm.
Topics: Antipsychotic Agents; Brain Neoplasms; Delusions; Female; Frontal Lobe; Humans; Magnetic Resonance I | 2017 |
Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Topics: Animals; Antineoplastic Agents, Alkylating; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proli | 2019 |
Carcinoid encephalopathy: A single entity or a spectrum of different disorders?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoid Tumor; Combined Mo | 2010 |
Brain tumor in a patient with attenuated psychosis syndrome.
Topics: Adolescent; Antipsychotic Agents; Brain Neoplasms; Cognitive Behavioral Therapy; Combined Modality T | 2013 |
Risperidone as an alternative treatment for paroxysmal kinesigenic dyskinesia.
Topics: Antipsychotic Agents; Brain Neoplasms; Chorea; Complementary Therapies; Female; Hematoma; Humans; Ma | 2003 |
Improvement of aggressive and antisocial behavior after resection of temporal lobe tumors.
Topics: Adolescent; Aggression; Anticonvulsants; Antipsychotic Agents; Brain Neoplasms; Child Behavior Disor | 2003 |
Severe extrapyramidal reaction due to risperidone in a case of neurofibromatosis.
Topics: Basal Ganglia Diseases; Brain Neoplasms; Humans; Male; Middle Aged; Neurofibroma; Neurofibromatoses; | 1997 |
Risperidone: a useful adjunct for behavioural disturbance in primary cerebral tumours.
Topics: Adult; Antipsychotic Agents; Behavioral Symptoms; Brain Neoplasms; Fatal Outcome; Glioblastoma; Huma | 2001 |